Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance

Overview of attention for article published in Investigational New Drugs, September 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 15 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Cancer treatment using FGFR inhibitors and PLK1 inhibitors

Grant US-11957677-B2

United States of America

CANCER TREATMENT USING FGFR INHIBITORS AND PLK1 INHIBITORS

Application US-20230124366-A1

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.